Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative

INTRODUCTION: Analyses of off‐label use of acetylcholinesterase inhibitors (AChEIs) in mild cognitive impairment (MCI) has produced mixed results. Post hoc analyses of observational cohorts, such as the Alzheimer's Disease Neuroimaging Initiative (ADNI), have reported deleterious effects in ACh...

Descripción completa

Detalles Bibliográficos
Autores principales: Stage, Eddie, Svaldi, Diana, Sokolow, Sophie, Risacher, Shannon L., Marosi, Krisztina, Rotter, Jerome I., Saykin, Andrew J., Apostolova, Liana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719350/
https://www.ncbi.nlm.nih.gov/pubmed/35005201
http://dx.doi.org/10.1002/trc2.12168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719350/
https://www.ncbi.nlm.nih.gov/pubmed/35005201
http://dx.doi.org/10.1002/trc2.12168

Ejemplares similares